| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/21/2004 | WO2004040972A2 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
| 05/21/2004 | WO2004026351A3 Improved ion triggerable, cationic polymers, a method of making same and items using same |
| 05/21/2004 | WO2004021973A3 Pravastatin pharmaceutical formulations and methods of their use |
| 05/21/2004 | WO2004016248A8 Galenic formulation for colon targeted delivery of active principles |
| 05/21/2004 | WO2004016244A3 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 05/21/2004 | WO2004016243A3 Methods of administering and enhancing absorption of pharmaceutical agents |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003077796A3 Ophthalmic solutions for delivery of expression vectors |
| 05/21/2004 | WO2003053399A3 Methods for wet granulating azithromycin |
| 05/21/2004 | WO2003020240A3 Therapeutic agent delivery tampon |
| 05/21/2004 | WO2003000485B1 Method and device for producing compression coated tablets |
| 05/21/2004 | WO2002067952A8 Prophylactic teat treatment |
| 05/21/2004 | WO2002062393A8 Coating for orally administered compositions |
| 05/21/2004 | WO2002060435A8 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 05/21/2004 | CA2718277A1 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | CA2513981A1 Implantable medical device for controlled release of a substance |
| 05/21/2004 | CA2507404A1 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
| 05/21/2004 | CA2504932A1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 05/21/2004 | CA2504842A1 Self-folding polymer microparticles |
| 05/21/2004 | CA2504706A1 Coating of a particulate material with an organic solvent-based coating composition |
| 05/21/2004 | CA2504479A1 Implantable structure for prolonged and controlled release of an active principle |
| 05/21/2004 | CA2504329A1 Geodate delivery vehicles |
| 05/21/2004 | CA2504283A1 Therapeutic compositions for drug delivery to and through covering epithelia |
| 05/21/2004 | CA2504038A1 Dosage form providing ascending release of liquid formulation |
| 05/21/2004 | CA2504031A1 Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs |
| 05/21/2004 | CA2504021A1 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | CA2503895A1 Single-use packaging |
| 05/21/2004 | CA2503661A1 Oral hygiene system and method of treatment |
| 05/21/2004 | CA2503150A1 Pharmaceutical formulations targeting specific regions of the gastrointestinal tract |
| 05/21/2004 | CA2502475A1 Dosage forms containing stabilized choline and method for preparing same |
| 05/21/2004 | CA2501324A1 Oral extended release tablets and methods of making and using the same |
| 05/21/2004 | CA2497848A1 Transmucosal pharmaceutical administration form |
| 05/21/2004 | CA2475577A1 Wet granulation process |
| 05/20/2004 | US20040098119 Stent with smooth ends |
| 05/20/2004 | US20040098072 Steam generator |
| 05/20/2004 | US20040097906 Osmotic delivery system with early zero order push power engine |
| 05/20/2004 | US20040097901 Methods for embolizing vascular sites with an embolizing composition |
| 05/20/2004 | US20040097864 Multi-purpose drug and heat therapy treatment system |
| 05/20/2004 | US20040097796 Method and system of monitoring a patient |
| 05/20/2004 | US20040097724 Organometallic building materials and method for producing the same |
| 05/20/2004 | US20040097592 Adding nonionic surfactant and antioxidant; preventing decomposition and container adsorption of prostaglandin derivative in ophthalmic solution |
| 05/20/2004 | US20040097582 Contacting abdominal organ with a blood-flow to abdominal organ decrease preventing agent for negating or reducing decrease in blood flow in an abdominal organ which would otherwise have decreased oxygen delivery because of decreased |
| 05/20/2004 | US20040097577 Use of at least one of melatonin, a melatonin analogue, or a pharmaceutically acceptable salt of melatonin or melatonin analogue, in the preparation of a medicament for the treatment of ADHD in a mammal, especially a human being |
| 05/20/2004 | US20040097536 Extended release oral dosage composition |
| 05/20/2004 | US20040097533 Useful as potassium channel blockers and antiarrhythmic drugs |
| 05/20/2004 | US20040097514 Sustained release ranolazine formulations |
| 05/20/2004 | US20040097512 Antibiotic compositions for treatment of the eye, ear and nose |
| 05/20/2004 | US20040097500 Compounds and compositions for delivering active agents |
| 05/20/2004 | US20040097489 2-methyl-thieno-benzodiazepine formulation |
| 05/20/2004 | US20040097484 Once a day galantamine pharmaceutical compositions and methods of use |
| 05/20/2004 | US20040097474 Administering formulation comprising anti-allergy agent selected from emedastine and olopatadine and steroid selected from the group consisting of fluticasone, mometasone, budesonide and beclomethasone for therapy of allergic rhinitis |
| 05/20/2004 | US20040097419 Organic compounds |
| 05/20/2004 | US20040097410 Dissolving drug in acidic aqueous buffered solution; adding surfactant and oil; agitation; oral administering |
| 05/20/2004 | US20040097404 Supplement to be enternally administered for parenteral nutrition or partial enteral/oral nurtrition of the critically ill, the chronically ill and people with malnutrition |
| 05/20/2004 | US20040096845 Peritoneal dialysates |
| 05/20/2004 | US20040096662 Embolization |
| 05/20/2004 | US20040096651 Pressure-sensitive adhesive sheet for medical use and process for producing the same |
| 05/20/2004 | US20040096569 Shapes indicating flavor; thin film; adhesion to mouth; therapy for oral diseases |
| 05/20/2004 | US20040096566 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 05/20/2004 | US20040096526 Using plant extracts mixtures; extraction, filtration, spray drying; beverages |
| 05/20/2004 | US20040096523 Reduces ability of mammal's leukocytes or platelets to become activated; administering potentiating compound; preventing nonpulmonary ischemia- reperfusion injury |
| 05/20/2004 | US20040096522 Synergistic mixtures |
| 05/20/2004 | US20040096521 Topical applying aspirin solutions |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/20/2004 | US20040096516 Modified carrier particles for use in dry powder inhalers |
| 05/20/2004 | US20040096515 Methods and compositions for encapsulating active agents |
| 05/20/2004 | US20040096514 For treatment of skin contour deficiencies, Gastro-esophageal reflux disease, urinary incontinence, and urinary reflux disease, using the injectable compositions. |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096512 Phospholipid composition and use of same |
| 05/20/2004 | US20040096511 Magnetically guidable carriers and methods for the targeted magnetic delivery of substances in the body |
| 05/20/2004 | US20040096508 A polymeric solution capable of gelling upon exposure to a critical minimum value of a plurality of environmental stimuli is disclosed. The polymeric solution may be an aqueous solution utilized in vivo and capable of having the gelation |
| 05/20/2004 | US20040096507 Novel hexa-arm polyethylene glycol and its derivatives and the methods of preparation thereof |
| 05/20/2004 | US20040096506 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 05/20/2004 | US20040096503 Dry-powder film coating composition and method of preparation |
| 05/20/2004 | US20040096502 Pharmaceutical pellets comprising tamsulosin |
| 05/20/2004 | US20040096501 Release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form. |
| 05/20/2004 | US20040096500 Reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is |
| 05/20/2004 | US20040096499 A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release |
| 05/20/2004 | US20040096498 Lipid, dry particles including at least one pharmaceutical, and at least one filler, wherein the dry particles are continuously coated by the lipid and form a homogeneous suspension with the lipid, wherein the suspension, when melted |
| 05/20/2004 | US20040096497 Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions |
| 05/20/2004 | US20040096496 Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| 05/20/2004 | US20040096494 Composition in the form of lipoglobules which comprises (a) one or more NO-releasing NSAID(s); (b) one or more surfactants and water as well as a composition for pain and inflamation |
| 05/20/2004 | US20040096493 Preparing a therapeutic formulation containing phosphate derivatives of electron transfer agents comprising steps of phosphorylation and P4O10 to form a mixture of at least one mono-electron transfer agent phosphate derivative and at least |
| 05/20/2004 | US20040096491 Adhesive patch |
| 05/20/2004 | US20040096490 Highly flexible transdermal therapeutic system having nicotine as active substance |
| 05/20/2004 | US20040096488 Wart treatment adhesive bandage and method of using same |
| 05/20/2004 | US20040096487 Treating healed wounds including hypertrophic scars so as to prevent scarring or reduce the size and improve the appearance of scars comprises applying to the healed wound or scar a composition comprising a fluid, film-forming carriers |
| 05/20/2004 | US20040096477 A drug delivery system comprising a contact lens having dispersed therein as nanoparticles having a particle size less than about 50 nm, an ophthalmic drug nanoencapsulated in a material from which said ophthalmic drug is capable of |
| 05/20/2004 | US20040096476 Polymeric anti-inflammatory agent that biodegrades to release antiinflammatory agents. The therapeutic devices are useful for repair and regeneration of a variety of injured tissues for wound healing agents |
| 05/20/2004 | US20040096455 Device for transdermally delivering an immunologically active agent, the device comprising: member having a plurality of stratum corneum-piercing microprotrusions and dry coating on said member; said coating, before drying, comprising an |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/20/2004 | US20040096422 Methods for reducing pain and organ dysfunction using bioadhesive, bioresorbable, anti-adhesion compositions made of intermacromolecular complexes of carboxyl-containing polysaccharides, polyethers, polyacids, polyalkylene oxides, |
| 05/20/2004 | US20040096410 Methods and compositions for treatment of dermal conditions |
| 05/20/2004 | US20040096405 Topical delivery of anti-alopecia agents |
| 05/20/2004 | US20040096403 Method for drug delivery to the pulmonary system |
| 05/20/2004 | US20040096402 Mixing a vapor, formed by heating a compound on a substrate, with a gas, in a ratio to form an aerosol with a mass median aerodynamic diameter of less than 1 mu m when a stable number concentration of particles in the gas is reached. |
| 05/20/2004 | US20040096401 Methods and compositions for the pulmonary delivery of insulin |
| 05/20/2004 | US20040096400 Methods and compositions for the pulmonary delivery insulin |
| 05/20/2004 | US20040096399 Inhalers containing a solution of an active ingredient in a hydrofluorocarbon propellant and a cosolvent; the internal surfaces consist of stainless steel, anodised aluminium or are lined with an inert organic coating. |